Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first21 to 40 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| BCL2 BCL2 apoptosis regulator | 596 HGNC:990 | 1 | 223 | 7 | 848 | 26,096 | 145,102 |
| MTOR mechanistic target of rapamycin kinase | 2475 HGNC:3942 | 1 | 142 | 29 | 210 | 33,350 | 142,439 |
| CASP3 caspase 3 | 836 HGNC:1504 | 1 | 176 | 1 | 11 | 29,773 | 140,116 |
| MYC MYC proto-oncogene, bHLH transcription factor | 4609 HGNC:7553 | 1 | 371 | 0 | 0 | 42,341 | 137,878 |
| IL2 interleukin 2 | 3558 HGNC:6001 | 1 | 1,257 | 0 | 0 | 33,709 | 131,649 |
| POTEF POTE ankyrin domain family member F | 728378 HGNC:33905 | 1 | 37 | 0 | 0 | 38,340 | 124,352 |
| CTNNB1 catenin beta 1 | 1499 HGNC:2514 | 1 | 251 | 1 | 8 | 28,782 | 119,281 |
| ESR1 estrogen receptor 1 | 2099 HGNC:3467 | 1 | 225 | 56 | 1,396 | 26,659 | 118,937 |
| APP amyloid beta precursor protein | 351 HGNC:620 | 1 | 352 | 13 | 124 | 28,210 | 109,783 |
| CD274 CD274 molecule | 29126 HGNC:17635 | 1 | 1,370 | 13 | 2,081 | 15,156 | 104,241 |
| IL4 interleukin 4 | 3565 HGNC:6014 | 1 | 400 | 2 | 5 | 27,546 | 101,232 |
| EGF epidermal growth factor | 1950 HGNC:3229 | 1 | 111 | 0 | 0 | 32,924 | 96,880 |
| FGB fibrinogen beta chain | 2244 HGNC:3662 | 1 | 156 | 6 | 40 | 16,391 | 95,087 |
| F2 coagulation factor II, thrombin | 2147 HGNC:3535 | 1 | 213 | 14 | 132 | 20,081 | 93,623 |
| STAT3 signal transducer and activator of transcription 3 | 6774 HGNC:11364 | 1 | 157 | 2 | 14 | 25,033 | 93,348 |
| HLA-A major histocompatibility complex, class I, A | 3105 HGNC:4931 | 1 | 113 | 0 | 0 | 21,603 | 91,008 |
| CD34 CD34 molecule | 947 HGNC:1662 | 1 | 76 | 0 | 0 | 18,937 | 88,789 |
| FN1 fibronectin 1 | 2335 HGNC:3778 | 1 | 56 | 7 | 26 | 28,633 | 88,228 |
| PDCD1 programmed cell death 1 | 5133 HGNC:8760 | 1 | 1,127 | 26 | 6,986 | 14,918 | 87,595 |
| REN renin | 5972 HGNC:9958 | 1 | 37 | 5 | 113 | 12,867 | 87,037 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=2
{
"data": {
"total": 193990,
"results": [
{
"id": "596",
"title": "BCL2: BCL2 apoptosis regulator",
"summary": "NCBI Gene 596. 1 protein, 223 patents, 7 drugs, 848 trials, 26,096 NIH grants and 145,102 papers.",
"record": "/library/genes/596",
"gene_id": 596,
"symbol": "BCL2",
"name": "BCL2 apoptosis regulator",
"hgnc_id": "HGNC:990",
"counts": {
"proteins": 1,
"patents": 223,
"drugs": 7,
"trials": 848,
"grants": 26096,
"papers": 145102
}
},
{
"id": "2475",
"title": "MTOR: mechanistic target of rapamycin kinase",
"summary": "NCBI Gene 2475. 1 protein, 142 patents, 29 drugs, 210 trials, 33,350 NIH grants and 142,439 papers.",
"record": "/library/genes/2475",
"gene_id": 2475,
"symbol": "MTOR",
"name": "mechanistic target of rapamycin kinase",
"hgnc_id": "HGNC:3942",
"counts": {
"proteins": 1,
"patents": 142,
"drugs": 29,
"trials": 210,
"grants": 33350,
"papers": 142439
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=3",
"request_id": "pgQjj9HfoAgyeF1d"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant